| CTLEX | CTYCX | CTLEX / CTYCX | |
| Total Expense Ratio | 0.93 | 1.44 | 65% |
| Annual Report Gross Expense Ratio | 0.93 | 1.44 | 65% |
| Fund Existence | 11 years | 14 years | - |
| Gain YTD | 3.893 | 1.396 | 279% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.72B | 5.34B | 88% |
| Annual Yield % from dividends | 2.52 | 2.46 | 102% |
| Returns for 1 year | 1.37 | 0.41 | 333% |
| Returns for 3 years | 31.71 | 23.06 | 137% |
| Returns for 5 years | 6.28 | -0.11 | -5,890% |
| Returns for 10 years | 59.68 | 28.01 | 213% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MUXYX | 31.42 | 0.27 | +0.87% |
| Victory S&P 500 Index Y | |||
| HWSCX | 69.48 | 0.59 | +0.86% |
| Hotchkis & Wiley Small Cap Value C | |||
| JEMCX | 50.06 | 0.31 | +0.62% |
| JPMorgan Emerging Markets Equity C | |||
| LYFAX | 18.53 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare A | |||
| CEMFX | 20.11 | -0.16 | -0.79% |
| Cullen Emerging Markets High Div I | |||